memantine and adamantane

memantine has been researched along with adamantane in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (20.00)18.2507
2000's2 (13.33)29.6817
2010's7 (46.67)24.3611
2020's3 (20.00)2.80

Authors

AuthorsStudies
Bormann, J; Hübers, M; Kornhuber, J; Riederer, P; Rusche, K1
Kornhuber, J; Riederer, P; Schoppmeyer, K; Weller, M1
Koshelev, S; Sobolevsky, A1
Shah, RC1
Lipton, SA1
Lukomskaia, NIa; Magazanik, LG; Vataev, SI; Zhabko, EP1
Gmiro, VE; Lukomskaia, NIa; Magazanik, LG; Oganesian, GA; Vataev, SI1
Lukomskaia, NIa; Magazanik, LG; Oganesian, GA; Vataev, SI1
Gmiro, VE; Serdyuk, SE; Veselkina, OS1
Schaefer, HF1
Gan'shina, TS; Gnedovskaya, EV; Kurza, EV; Maslennikov, DV; Mirzoyan, RS; Shabalina, AA; Tanashyan, MM1
Henter, ID; Lepow, L; Luckenbaugh, DA; Park, L; Zarate, CA1
Grieb, P; Rejdak, K1
Brenner, SR1
Kwon, DY; Park, MH1

Reviews

2 review(s) available for memantine and adamantane

ArticleYear
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
    Journal of neural transmission. Supplementum, 1994, Volume: 43

    Topics: Adamantane; Amantadine; Animals; Behavior, Animal; Dopamine; Electrophysiology; Hallucinogens; Humans; Memantine; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Substance-Related Disorders

1994
Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Current drug targets, 2007, Volume: 8, Issue:5

    Topics: Adamantane; Alzheimer Disease; Animals; Dementia, Vascular; Humans; Memantine; Neuroprotective Agents; Nitric Acid; Receptors, N-Methyl-D-Aspartate

2007

Other Studies

13 other study(ies) available for memantine and adamantane

ArticleYear
Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.
    European journal of pharmacology, 1991, Apr-25, Volume: 206, Issue:4

    Topics: Adamantane; Amantadine; Binding Sites; Brain; Dizocilpine Maleate; Humans; Ion Channel Gating; Ion Channels; Kinetics; Memantine; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Tritium

1991
Two blocking sites of amino-adamantane derivatives in open N-methyl-D-aspartate channels.
    Biophysical journal, 1998, Volume: 74, Issue:3

    Topics: Adamantane; Amantadine; Animals; Binding Sites; Cell Membrane; Cell Separation; Hippocampus; In Vitro Techniques; Kinetics; Memantine; Membrane Potentials; Models, Chemical; Models, Molecular; Patch-Clamp Techniques; Pyramidal Cells; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship

1998
Shift shown in influenza A adamantane resistance.
    JAMA, 2006, Oct-04, Volume: 296, Issue:13

    Topics: Adamantane; Alzheimer Disease; Antiviral Agents; Drug Resistance, Viral; Excitatory Amino Acid Antagonists; Humans; Influenza A virus; Influenza, Human; Memantine

2006
[Effects of ionotropic glutamate receptor channel blockers on the development of audiogenic seizures in Krushinski-Molodkina rats].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2012, Volume: 98, Issue:4

    Topics: Acoustic Stimulation; Adamantane; Animals; Cyclohexylamines; Diamines; Drug Administration Schedule; Epilepsy, Reflex; Excitatory Amino Acid Antagonists; Injections, Intramuscular; Male; Memantine; Motor Activity; Quaternary Ammonium Compounds; Rats; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Seizures

2012
[Effects of ionotropic glutamate receptor channel blockers ON sleep-waking organization in rats].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2012, Volume: 98, Issue:7

    Topics: Adamantane; Animals; Cyclohexylamines; Diamines; Epilepsy, Reflex; Excitatory Amino Acid Antagonists; Male; Memantine; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Sleep

2012
[The action of ionotropic glutamate receptor channel blockers on effects of sleep deprivation in rats].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2013, Volume: 99, Issue:5

    Topics: Adamantane; Animals; Cyclohexylamines; Diamines; Electroencephalography; Injections, Intramuscular; Male; Memantine; Quaternary Ammonium Compounds; Rats; Rats, Transgenic; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Sleep Deprivation; Sleep, REM; Wakefulness

2013
Combined blockade of NMDA and AMPA receptors prevents acute kainate seizures and chronic kainate lethality in rats.
    Bulletin of experimental biology and medicine, 2014, Volume: 157, Issue:1

    Topics: Adamantane; Amines; Animals; Anticonvulsants; Convulsants; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Injections, Intramuscular; Kainic Acid; Male; Memantine; N-Methylaspartate; Neuroprotective Agents; Pentylenetetrazole; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Seizures; Survival Analysis

2014
Paul von Ragué Schleyer (1930-2014).
    Nature, 2015, Jan-01, Volume: 517, Issue:7532

    Topics: Adamantane; Chemistry; Dipeptides; Germany; History, 20th Century; Memantine; Nobel Prize; United States

2015
[ANTIPLATELET AND ANTI-ISCHEMIC EFFECTS OF MEMANTINE AND 5-HYDROXYADAMANTAN-2-ONE IN PATIENTS WITH CEREBROVASCULAR PATHOLOGY AND IN EXPERIMENTS].
    Eksperimental'naia i klinicheskaia farmakologiia, 2016, Volume: 79, Issue:2

    Topics: Adamantane; Adenosine Diphosphate; Aged; Animals; Animals, Outbred Strains; Blood Platelets; Cells, Cultured; Cerebral Cortex; Cerebrovascular Circulation; Epinephrine; Excitatory Amino Acid Antagonists; Female; Humans; Hypoxia-Ischemia, Brain; Ischemic Attack, Transient; Laser-Doppler Flowmetry; Male; Memantine; Middle Aged; Nimodipine; Platelet Aggregation; Rats; Vasodilator Agents

2016
Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects.
    Journal of psychiatric research, 2017, Volume: 86

    Topics: Adamantane; Adult; Antidepressive Agents; Depression; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Memantine; Middle Aged; Niacinamide; Predictive Value of Tests; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Treatment Outcome

2017
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
    Multiple sclerosis and related disorders, 2020, Volume: 42

    Topics: Adamantane; Adult; Aged; Aged, 80 and over; Amantadine; Asymptomatic Infections; Betacoronavirus; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dopamine Agents; Female; Humans; Male; Memantine; Middle Aged; Multiple Sclerosis; Pandemics; Parkinson Disease; Pneumonia, Viral; Protective Factors; SARS-CoV-2; Severity of Illness Index

2020
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.
    Journal of medical virology, 2020, Volume: 92, Issue:11

    Topics: Adamantane; Amantadine; COVID-19; Humans; Lysosomes; Memantine; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Virus Replication

2020
A retrospective review of memantine use and COVID-19-associated mortality from a national database.
    Journal of medical virology, 2021, Volume: 93, Issue:1

    Topics: Adamantane; COVID-19; Humans; Memantine; Retrospective Studies; SARS-CoV-2

2021